3D cell culture providing more accurate data and more physiologically relevant information in vivo tests, it has become acceptable in comparison to 2D Cell culture. The technology of tissue regeneration has enabled the growth and repair of cells in the human body. The technique known as 3D cell culture helps biological cells to grow or interact with their surroundings in all three dimensions.

Key Findings

The global 3D cell culture market was USD 725.15 million in 2016
Consumables are the largest segment, by product which is projected to grow at a CAGR of 25.88% during the forecast period from 2017–2023
Drug discovery is the largest segment, by application for the global 3D cell culture and expected to grow at a rate of CAGR 25.75% during the forecast period
The Pharmaceutical & Biotechnology Companies segment and is expected grow with the CAGR of 26.13% for the forecast period.
3D cell culture is a technique in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Besides, the ability of 3D cell culture to provide more physiologically relevant information and more accurate data in vivo tests has led 3D cell culture systems to become acceptable in comparison to 2D Cell culture.

Avail Sample Copy for This Report at: https://www.marketresearchfuture.com/sample_request/5928

Market Research Future (MRFR) has published a research report about the global 3D cell culture market that anticipates the growth of this market between 2017 and 2023, with 25% CAGR (Compound Annual Growth Rate).

Top key players in the global 3D cell culture market include Becton-Dickinson and Company (USA), Charles River Laboratories Inc (USA), Corning Incorporated (USA), The Electrospinning Company (UK), InSphero, AG (Switzerland), Kuraray Co Ltd (Japan), Lonza (Switzerland), Lena Biosciences Inc. (USA), Merck KGaA (Germany), Tecan Trading AG (Switzerland), ReproCELL Europe Ltd (UK), and Thermo Fisher Scientific Inc. (USA).

The key findings of this report mention that by the end of forecast period, by product segmentation, consumables will be the highest growing segment of the global 3D cell culture market, with a CAGR of 25.88%.

At the same time, among application, drug discovery will emerge as the largest segment with 25.75%. As a whole segment, The Pharmaceutical & Biotechnology Companies is expected to witness maximum growth with the CAGR of 26.13%.

The regional segmentation of the global 3D cell culture market covers The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). With many key players based in the United States of America (USA) and due to the availability of advanced technology, North America is a bigger market than South America. In the USA, maximum organ transplant surgeries have taken place since 2016. In Europe, due to reasons same as North America, being more advanced technologically, Western Europe is a bigger market than Eastern Europe.

Rising demand for organ transplantation might raise the 3D Cell Culture Market with 25% CAGR between 2017 and 2023.

To develop the field of tissue engineering in order to regenerate damaged tissues, the cells from the body are combined with highly porous scaffold biomaterials that act as templates for tissue regeneration and guides the growth of new tissue. A technique based on scaffold biomaterials is called scaffolds based on 3D cell culture. Scaffold-free methods include the use of hanging drop plates, low adhesion plates, magnetic 3D bioprinting, magnetic levitation, micropatterned surfaces, and rotating bioreactors.

Brows Detailed Report at:  https://www.marketresearchfuture.com/reports/3d-cell-culture-market-5928

Latest Industry News:

ALPCO, a leading producer of research and clinical immunoassays, has announced its partnership with InSphero, AG. This partnership aims to provide customers with a complete solution to assess beta-cell function in islet micro tissue culture models. 24 JUL 2018
Collaborating with the University of Strathclyde, Biotechnology giant AMSBIO has set up a new joint venture company called ScreenIn3D, exploiting the latest advances in microfluidics and 3D cell culture, to develop a novel microfluidic screening platform. 6 JUL 2018.
The market growth in this region can be attributed to the rising expenditure for the healthcare sector and improving healthcare infrastructure. Avail Discount Enquiry for this Report.

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future

+1 646 845 9312

Email: [email protected]